Health Canada
- Status: approved
Intermittent bolus infusion of levobupivacaine (Intermittent bolus infusion of levobupivacaine) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
University Hospital, Antwerp is the originator. The local marketing authorisation holder may differ — check the official source linked above.